Skip to main content

Table 2 Nucleotide diversity and neutrality tests for the analysed gene regions

From: Balancing selection is common in the extended MHC region but most alleles with opposite risk profile for autoimmune diseases are neutrally evolving

Gene

La

Pb

Sc

θWd

Ï€e

Tajima's D

Fu & Li's D*

Fu & Li's F*

    

value

rankf

value

rankf

value

rankf

p g

value

rankf

p g

value

rankf

p g

ZSCAN23

3.3

CEU

7

4.96

0.44

6.52

0.66

0.87

0.78

0.20

0.51

0.72

0.34

0.73

0.74

0.25

VARS2

3.2

CEU

10

7.30

0.69

10.78

0.86

1.43

0.89

0.09

0.24

0.65

0.40

0.73

0.74

0.25

HLA-DMB

3.1

CEU

14

10.60

0.91

12.12

0.89

0.45

0.66

0.30

-0.28

0.47

0.60

-0.050

0.54

0.51

PTPN22

3.5

CEU

7

4.70

0.44

4.57

0.41

-0.077

0.51

0.49

-0.98

0.23

0.80

-0.81

0.31

0.75

BAT3

2.0

CEU

3

3.47

0.21

3.14

0.27

-0.20

0.47

0.57

-0.35

0.46

0.64

-0.36

0.44

0.62

C6orf47

2.0

CEU

3

3.59

0.21

5.21

0.48

0.98

0.81

0.18

0.92

0.85

0.19

1.09

0.84

0.13

IL10

2.3

CEU

3

2.97

0.15

5.95

0.55

2.12

0.97

0.01

0.90

0.84

0.16

1.47

0.94

0.04

CDSN/

4.5

CEU

59

30.80

>0.99

49.42

>0.99

2.17

0.97

0.01

1.40

0.95

0.03

1.98

0.97

0.01

PSORSC1

                
  

YRI

63

32.88

>0.99

46.20

>0.99

1.46

0.99

0.01

1.44

>0.99

<0.01

1.72

>0.99

<0.01

  

EAS

64

33.41

>0.99

47.50

>0.99

1.52

0.91

0.08

1.45

0.98

001

1.75

0.98

0.02

TRIM40/

9.1

CEU

68

17.51

0.98

26.13

0.99

1.78

0.96

0.03

1.61

0.98

<0.01

1.98

0.97

<0.01

TRIM10

                
  

YRI

64

16.48

0.96

15.74

0.94

-0.16

0.64

0.22

1.07

0.97

<0.01

0.76

0.93

0.02

  

EAS

79

20.34

0.99

19.33

0.98

-0.18

0.46

0.31

-0.20

0.46

0.68

-0.23

0.45

0.71

BTNL2

3.8

CEU

53

33.04

>0.99

39.75

0.99

-0.33

0.42

0.36

1.32

0.93

0.03

0.88

0.78

0.15

  

YRI

63

39.28

>0.99

30.01

>0.99

0.043

0.71

0.18

0.67

0.89

0.06

0.53

0.86

0.07

  

EAS

94

58.60

>0.99

47.38

>0.99

-0.70

0.31

0.21

0.95

0.88

0.13

0.43

0.69

0.35

TAP2

4.4

CEU

33

17.56

0.98

29.07

0.99

2.27

0.98

0.01

1.59

0.98

0.01

2.16

0.98

<0.01

  

YRI

54

28.73

>0.99

34.55

>0.99

0.73

0.94

0.05

1.63

>0.99

<0.01

1.56

0.99

<0.01

  

EAS

41

21.81

0.99

32.88

>0.99

1.79

0.97

0.04

1.30

0.96

0.04

1.74

0.98

0.02

TAP2-ctr

2.6

CEU

12

10.71

0.91

12.18

0.89

0.42

0.65

0.32

0.46

0.70

0.29

0.52

0.69

0.18

BTNL2-ctr

2.0

CEU

15

17.47

0.98

16.73

0.96

-0.14

0.50

0.54

1.56

0.97

0.01

1.18

0.90

0.09

  1. a length of analyzed sequenced region (kb);
  2. b sampled population (for each population 40 chromosomes were resequenced);
  3. c number of segregating sites;
  4. d Watterson's theta estimation per site (×10-4);
  5. e nucleotide diversity per site (×10-4);
  6. f percentile rank relative to a distribution of 238 5kb segments from NIEHS genes;
  7. g p value applying demographic coalescent simulations.